A new weekly weight-loss injection is set to be rolled out across England's National Health Service (NHS), offering hope to millions of patients at heightened risk of heart attacks and strokes.
The drug, known as Wegovy (semaglutide), has been approved by the National Institute for Health and Care Excellence (NICE) as an additional treatment for people already living with cardiovascular disease and obesity.
